Search Results

Ulnar Access for Catheterization and Intervention

When and how radial operators should consider transulnar access as an alternative to transfemoral access.

By Safi U. Khan, MD; Michael DePersis, DO; and Edo Kaluski, MD, FACC, FESC, FSCAI

Radial Access

By Ted E. Feldman, MD, MSCAI, FACC, FESC

Performing Tip-to-Base LAMPOON

A step-by-step review of this technique to prevent LVOT obstruction from TMVR.

By Jaffar M. Khan, BM BCh, PhD; Adam B. Greenbaum, MD; Toby Rogers, MD, PhD; Christopher G. Bruce, MBChB; Vasilis C. Babaliaros, MD; and Robert J. Lederman, MD

Percutaneous Closure of Mitral Prosthetic Paravalvular Leak

A discussion of the disease etiology, treatment techniques, and outcomes of percutaneous PVL repair, as well as an illustrative case report.

By Reza Sepehrdad, MD, and Jason H. Rogers, MD

Should all aortic stenosis patients older than 80 years undergo TAVR rather than SAVR?

With Gregory Mishkel, MD, FRCPC, FACC, FSCAI; Vikas Aggarwal, MD, FACC; Paul J. Pearson, MD, PhD; Vinod H. Thourani, MD, FACC, FACS; Jessica Forcillo, MD, MSc, FRCSC; and Nicolas M. Van Mieghem, MD, PhD, FESC

MitraClip for Functional MR

A review of MitraClip use and the COAPT trial in the heart failure population.

By Mike Saji, MD, and D. Scott Lim, MD

Reaching TAVR's Full Potential by Optimizing Postprocedure Care

Realizing the potential benefits that can be gained when clinical pathways are implemented post-TAVR.

By Christopher U. Meduri, MD, MPH; Vivek Rajagopal, MD; Jim Kauten, MD; Charles Brown IV, BA; David Alexander, PA; Edvin K. Feldt, MD; and Brian J. Potter, MD, MSc

Drug-Eluting Stents for Off-Label Indications

A review of studies comparing DES to BMS for on- and off-label uses.

By Sameer J. Khandhar, MD; Suresh R. Mulukutla, MD, FACC, FSCAI; and Oscar C. Marroquin, MD, FACC, FSCAI

Percutaneous Coronary Intervention in Cardiogenic Shock

A review of the current and evolving percutaneous interventions.

By Amar R. Chadaga, MD, and Timothy A. Sanborn, MD

Neuromodulation in Heart Failure: Proven and Emerging Solutions

A summary of the pathophysiologic rationale and latest clinical evidence for the role of interventional neuromodulating therapies in treating heart failure.

By Felix Götzinger, MD; Lucas Lauder, MD; and Felix Mahfoud, MD, MA

Physiologic Lesion Assessment

Fractional flow reserve has become an indispensable tool in guiding the decision for PCI in intermediate lesions and likely improves outcomes in patients undergoing multivessel PCI.

By William F. Fearon, MD

Percutaneous Device Closure of Congenital VSDs

Current techniques and results for treating ventricular septal defects.

By Karim A. Diab, MD; Qi-Ling Cao, MD; and Ziyad M. Hijazi, MD, MPH

Preparing Health Systems for Broader TAVR Access

A three-pillar framework for diagnostics, clinical workflows, and operational planning to support expanding TAVR eligibility.

By Sumit R. Kumar, MD, MPA; Natalia C. Berry, MD, MBA, FACC; James T. DeVries, MD, FACC; Henry J. Tannous, MD; and Michael N. Young, MD, FACC, FSCAI, RPVI

Considerations for ASD Closure

Understanding the devices and proper anatomic evaluation to prevent and manage possible complications.

By Paul Poommipanit, MD, FSCAI, FACC, and Zahid Amin, MD, FSCAI, FAAP, FACC, FAHA

An Interview With Ulrich Schäfer, MD

Prof. Schäfer shares updates on the current status of therapies for each of the four heart valves, as well as new technologies to address heart failure and more.

STEMI Care and Shock in Female Patients

Measures to adopt to advance primary and secondary prevention strategies that directly target women.

By Mansi Oberoi, MD; M. Chadi Alraies, MD; and Poonam Velagapudi, MD, MS